Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer
- PMID: 12151971
- DOI: 10.1097/00000421-200208000-00014
Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer
Abstract
A 60-year-old woman with a history of unresectable colon adenocarcinoma was treated by chemotherapy with a combination of oxaliplatin with leucovorin and fluorouracil. Progressive dyspnea and bilateral pulmonary interstitial infiltrates developed. Bronchoscopy with bronchoalveolar lavage confirmed pulmonary eosinophilia. Clinical and radiologic aspects of eosinophilic lung disease cleared after cessation of this combination of chemotherapy and did not recur after reintroduction of leucovorin/fluorouracil alone, suggesting that oxaliplatin was the causative agent. Care was taken to rule out other possible causes for eosinophilic pneumonia.
Similar articles
-
Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.Arch Bronconeumol. 2017 Apr;53(4):213-215. doi: 10.1016/j.arbres.2016.08.010. Epub 2016 Oct 15. Arch Bronconeumol. 2017. PMID: 27756654 English, Spanish. No abstract available.
-
[Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].Korean J Gastroenterol. 2010 May;55(5):340-3. doi: 10.4166/kjg.2010.55.5.340. Korean J Gastroenterol. 2010. PMID: 20697195 Korean.
-
Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.Jpn J Clin Oncol. 2007 Jun;37(6):434-9. doi: 10.1093/jjco/hym068. Jpn J Clin Oncol. 2007. PMID: 17656481
-
Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.Drugs. 2000 Oct;60(4):895-924. doi: 10.2165/00003495-200060040-00005. Drugs. 2000. PMID: 11085200 Review.
-
[Standard chemotherapy for colonic neoplasms].Nihon Naika Gakkai Zasshi. 2007 Feb 10;96(2):283-8. doi: 10.2169/naika.96.283. Nihon Naika Gakkai Zasshi. 2007. PMID: 17370594 Review. Japanese. No abstract available.
Cited by
-
A phase ΙI study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study).J Transl Med. 2014 Apr 30;12:108. doi: 10.1186/1479-5876-12-108. J Transl Med. 2014. PMID: 24884643 Free PMC article. Clinical Trial.
-
Oxaliplatin-induced lung injury with allergic reaction.Chin J Cancer Res. 2011 Sep;23(3):232-5. doi: 10.1007/s11670-011-0232-y. Chin J Cancer Res. 2011. PMID: 23467619 Free PMC article.
-
Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.Clin Transl Oncol. 2005 Dec;7(11):515-7. doi: 10.1007/BF02717006. Clin Transl Oncol. 2005. PMID: 16373064
-
Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature.Case Rep Oncol Med. 2015;2015:341064. doi: 10.1155/2015/341064. Epub 2015 May 10. Case Rep Oncol Med. 2015. PMID: 26064729 Free PMC article.
-
Pulmonary Fibrosis Secondary to Oxaliplatin Treatment: From Rarity to Reality: A Case Study and Literature Review.Oncol Ther. 2020 Dec;8(2):183-190. doi: 10.1007/s40487-020-00127-z. Epub 2020 Sep 3. Oncol Ther. 2020. PMID: 32880815 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical